3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Triple Negative Breast Neoplasms
4
Carcinoma, Adenoid Cystic
2
Resectable HER2-positive Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Lymphoma, B-Cell, Marginal Zone
1
Inflammatory Breast Neoplasms
1
Down Syndrome
1
Interventions
Cyclophosphamide
12
Vincristine
9
Etoposide
8
venetoclax
6
Methotrexate
6
Doxorubicin
6
Dexamethasone
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
prednylidene
4
pegaspargase
4
merphos
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
deltacortene
4
calaspargase pegol
4
auricularum
4
Specimen Handling
4
Granulocyte Colony-Stimulating Factor
4
fludarabine phosphate
3
daratumumab
3
Thioguanine
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mercaptopurine
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Hydrocortisone
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Epirubicin
×
90 days
×
Clear all
No trials found.